Isoagglutinin titre adsorption: Breaking the barrier in major AB0-incompatible organ transplantation

Transfusion and Apheresis Science

Volumn 41, Issue 1, 2009, Pages 45-48

  Wilde, Benjamin ^a   Pietruck, Frank ^a   Kribben, Andreas ^a   Witzke, Oliver ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Blood group; Immunosuppression; Renal transplantation

Indexed keywords

AZATHIOPRINE; BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; CREATININE; CYCLOSPORIN; IMMUNOGLOBULIN; INTRATECT; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CASE REPORT; COOMBS TEST; CREATININE BLOOD LEVEL; DRUG MECHANISM; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; MALE; NEPHROSCLEROSIS; ORGAN DONOR; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE TREATMENT;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; BIOPSY; BLOOD GROUP INCOMPATIBILITY; CREATININE; GRAFT SURVIVAL; HEMAGGLUTININS; HUMANS; IMMUNITY, HUMORAL; IMMUNOLOGIC FACTORS; KIDNEY TRANSPLANTATION; LIVING DONORS;

EID: 67651207511     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2009.05.012     Document Type: Article

References (22)

1. Witzke O., Pietruck F., Paul A., Broelsch C.E., and Philipp T. Cross-over kidney transplantation in Germany. Dtsch Med Wochenschr 130 (2005) 2699-2702
2. Stegall M.D., Dean P.G., and Gloor J.M. AB0-incompatible kidney transplantation. Transplantation 78 (2004) 635-640
3. Takahashi K. AB0-incompatible kidney transplantation. Jpn J Transplant 33 (1998) 145-160
4. Rydberg L., Norden G., Mjornstedt L., et al. Five years experience of an AB0-incompatible living donor renal transplant program. Tissue Antigens 69 (2007) 479
5. Matignon M., Dahan K., Fruchaud G., Audard V., Grimbert P., and Lang P. Kidney transplantation: indications, results, limitations, and perspectives. Presse Medicale 36 (2007) 1829-1834
6. Tanabe K. Japanese experience of AB0-incompatible living kidney transplantation. Transplantation 84 (2007) S4-S7
7. Ishida H., Miyamoto N., Shirakawa H., et al. Evaluation of immunosuppressive regimens in AB0-incompatible living kidney transplantation - Single center analysis. Am J Transplant 7 (2007) 825-831
8. Tyden G., Donauer J., Wadstrom J., et al. Implementation of a protocol for AB0-incompatible kidney transplantation - A three-center experience with 60 consecutive transplantations. Transplantation 83 (2007) 1153-1155
9. Hugo C., Schott G., Eckardt K.U., and Wullich B. AB0-incompatible renal transplantation-why and how?. Urologe A 47 (2008) 1074-1078
10. Genberg H., Kumlien G., Wennberg L., Berg U., and Tyden G. AB0-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A 3-year follow-up. Transplantation 85 (2008) 1745-1754
11. Tyden G., Kumlien G., Genberg H., et al. The Stockholm experience with AB0-incompatible kidney transplantations without splenectomy. Xenotransplantation 13 (2006) 105-107
12. Gloor J.M., Lager D.J., Fidler M.E., et al. A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in AB0-incompatible kidney transplantation. Transplantation 80 (2005) 1572-1577
13. Gloor J., and Stegall M. AB0-incompatible kidney transplantation with and without splenectomy. Transplantation 82 (2006) 720
14. Takahashi K. Recent findings in AB0-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to AB0-blood-group-related antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol 11 (2007) 128-141
15. Takahashi K. A new concept of accommodation in AB0-incompatible kidney transplantation. Clin Transplant 19 Suppl. 14 (2005) 76-85
16. Takahashi K., and Saito K. Present status of AB0-incompatible kidney transplantation in Japan. Xenotransplantation 13 (2006) 118-122
17. Takahashi K., Saito K., Takahara S., et al. Excellent long-term outcome of AB0-incompatible living donor kidney transplantation in Japan. Am J Transplant 4 (2004) 1089-1096
18. Park W.D., Grande J.P., Ninova D., et al. Accommodation in AB0-incompatible kidney allografts, a novel mechanism of self-protection against anti body-mediated injury. Am J Transplant 3 (2003) 952-960
19. Ishida H., Shimizu T., Shirakawa H., et al. Evaluation of immunosuppressive regimens for AB0-incompatible living kidney transplantation. Splenectomy or rituximab? In combination with FK/MMF. Am J Transplant 8 (2008) 321
20. Ishida H., Shimizu T., Shirakawa H., et al. Low incidence of humoral rejection despite the continued presence of anti-blood type antibodies since the start of FK/MMF induction therapy in AB0-Incompatible kidney transplantations (AB0-ILKT). Am J Transplant 7 (2007) 519
21. Tobian A.A., Shirey R.S., Montgomery R.A., Ness P.M., and King K.E. The critical role of plasmapheresis in AB0-incompatible renal transplantation. Transfusion 48 11 (2008) 2453-2460
22. Shimmura H., Tanabe K., Ishida H., et al. Lack of correlation between results of AB0-incompatible living kidney transplantation and anti-AB0 blood type antibody titers under our current immunosuppression. Transplantation 80 (2005) 985-988